Norway Savings Bank’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.88M | Buy |
4,829
+173
| +4% | +$73.1K | 0.79% | 40 |
|
|
2026
Q1 | $2.2M | Buy |
4,656
+88
| +2% | +$44.3K | 1.04% | 36 |
|
|
2025
Q4 | $2.13M | Buy |
4,568
+313
| +7% | +$145K | 0.99% | 33 |
|
|
2025
Q3 | $1.81M | Buy |
4,255
+374
| +10% | +$145K | 0.88% | 40 |
|
|
2025
Q2 | $1.49M | Buy |
3,881
+499
| +15% | +$180K | 0.76% | 45 |
|
|
2025
Q1 | $1.17M | Buy |
3,382
+1,164
| +52% | +$374K | 0.66% | 52 |
|
|
2024
Q4 | $666K | Buy |
2,218
+397
| +22% | +$139K | 0.37% | 74 |
|
|
2024
Q3 | $740K | Buy |
1,821
+358
| +24% | +$131K | 0.4% | 76 |
|
|
2024
Q2 | $470K | Buy |
1,463
+280
| +24% | +$91K | 0.27% | 80 |
|
|
2024
Q1 | $395K | Buy |
1,183
+404
| +52% | +$123K | 0.16% | 116 |
|
|
2023
Q4 | $211K | Buy |
+779
| New | +$193K | 0.09% | 137 |
|
|
2023
Q1 | – | Sell |
-97
| Closed | -$23.3K | – | 197 |
|
|
2022
Q4 | $23.3K | Hold |
97
| – | – | 0.01% | 217 |
|
|
2022
Q3 | $18K | Sell |
97
-2,437
| -96% | -$485K | 0.01% | 229 |
|
|
2022
Q2 | $426K | Buy |
2,534
+67
| +3% | +$14.4K | 0.22% | 105 |
|
|
2022
Q1 | $618K | Buy |
2,467
+165
| +7% | +$41.4K | 0.28% | 92 |
|
|
2021
Q4 | $591K | Buy |
2,302
+20
| +0.9% | +$4.89K | 0.26% | 96 |
|
|
2021
Q3 | $554K | Buy |
2,282
+341
| +18% | +$83.4K | 0.26% | 94 |
|
|
2021
Q2 | $401K | Sell |
1,941
-345
| -15% | -$70.3K | 0.2% | 105 |
|
|
2021
Q1 | $431K | Sell |
2,286
-60
| -3% | -$10.6K | 0.23% | 98 |
|
|
2020
Q4 | $386K | Sell |
2,346
-388
| -14% | -$56.7K | 0.22% | 93 |
|
|
2020
Q3 | $341K | Sell |
2,734
-140
| -5% | -$17.3K | 0.23% | 91 |
|
|
2020
Q2 | $279K | Sell |
2,874
-1,405
| -33% | -$146K | 0.21% | 96 |
|
|
2020
Q1 | $384K | Buy |
4,279
+120
| +3% | +$15.5K | 0.33% | 80 |
|
|
2019
Q4 | $614K | Sell |
4,159
-196
| -5% | -$26.3K | 0.45% | 66 |
|
|
2019
Q3 | $524K | Sell |
4,355
-5
| -0.1% | -$646 | 0.43% | 64 |
|
|
2019
Q2 | $590K | Sell |
4,360
-15
| -0.3% | -$1.9K | 0.5% | 55 |
|
|
2019
Q1 | $571K | Buy |
4,375
+65
| +2% | +$8.73K | 0.5% | 56 |
|
|
2018
Q4 | $536K | Buy |
4,310
+200
| +5% | +$26.8K | 0.53% | 55 |
|
|
2018
Q3 | $572K | Sell |
4,110
-75
| -2% | -$9.34K | 0.5% | 58 |
|
|
2018
Q2 | $429K | Buy |
4,185
+130
| +3% | +$13.2K | 0.39% | 63 |
|
|
2018
Q1 | $394K | Buy |
+4,055
| New | +$393K | 0.37% | 66 |
|
Other funds holding HCA
Norway Savings Bank's HCA Position: Q2 2026 in Review
Norway Savings Bank increased its HCA Healthcare (HCA) stake by 3.7% in Q2 2026, buying an estimated $73.1K and bringing the position to 4,829 shares worth $1.88M. The position accounts for 0.79% of the portfolio, ranked #40.
Norway Savings Bank first reported a position in HCA in Q1 2018 and has held it in 31 quarters since. The position peaked at $2.2M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Norway Savings Bank held 4,829 shares of HCA Healthcare worth $1.88M as of Q2 2026.
- Norway Savings Bank bought 173 HCA Healthcare shares in Q2 2026, an estimated $73.1K.
- HCA Healthcare made up 0.79% of Norway Savings Bank's portfolio in Q2 2026, its #40 holding.
- Norway Savings Bank first reported a position in HCA Healthcare in Q1 2018 and has held it in 31 quarters since.
- Norway Savings Bank's HCA Healthcare position peaked at $2.2M in Q1 2026.
- 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Norway Savings Bank's 13F filing for Q2 2026, filed 8 Jul 2026.